Pituitary ACTH Hypersecretion Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL PITUITARY ACTH HYPERSECRETION DRUG INDUSTRY

2.1 Summary about Pituitary ACTH Hypersecretion Drug Industry

2.2 Pituitary ACTH Hypersecretion Drug Market Trends

2.2.1 Pituitary ACTH Hypersecretion Drug Production & Consumption Trends

2.2.2 Pituitary ACTH Hypersecretion Drug Demand Structure Trends

2.3 Pituitary ACTH Hypersecretion Drug Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 AT-814

4.2.2 ATR-101

4.2.3 BIM-23A758

4.2.4 COR-005

4.2.5 CORT-125134

4.2.6 ISIS-GCCRRx

4.2.7 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Clinic

4.3.2 Hospital

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 AT-814

5.2.2 ATR-101

5.2.3 BIM-23A758

5.2.4 COR-005

5.2.5 CORT-125134

5.2.6 ISIS-GCCRRx

5.2.7 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Clinic

5.3.2 Hospital

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 AT-814

6.2.2 ATR-101

6.2.3 BIM-23A758

6.2.4 COR-005

6.2.5 CORT-125134

6.2.6 ISIS-GCCRRx

6.2.7 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Clinic

6.3.2 Hospital

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 AT-814

7.2.2 ATR-101

7.2.3 BIM-23A758

7.2.4 COR-005

7.2.5 CORT-125134

7.2.6 ISIS-GCCRRx

7.2.7 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Clinic

7.3.2 Hospital

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 AT-814

8.2.2 ATR-101

8.2.3 BIM-23A758

8.2.4 COR-005

8.2.5 CORT-125134

8.2.6 ISIS-GCCRRx

8.2.7 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Clinic

8.3.2 Hospital

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 AT-814

9.2.2 ATR-101

9.2.3 BIM-23A758

9.2.4 COR-005

9.2.5 CORT-125134

9.2.6 ISIS-GCCRRx

9.2.7 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Clinic

9.3.2 Hospital

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Alder Biopharmaceuticals Inc.

10.1.2 Corcept Therapeutics Incorporated

10.1.3 Cortendo AB

10.1.4 Cyclacel Pharmaceuticals, Inc.

10.1.5 ElexoPharm GmbH

10.1.6 Ipsen S.A.

10.1.7 Isis Pharmaceuticals, Inc.

10.1.8 Novartis AG

10.1.9 Orphagen Pharmaceuticals, Inc.

10.1.10 Pfizer Inc.

10.2 Pituitary ACTH Hypersecretion Drug Sales Date of Major Players (2017-2020e)

10.2.1 Alder Biopharmaceuticals Inc.

10.2.2 Corcept Therapeutics Incorporated

10.2.3 Cortendo AB

10.2.4 Cyclacel Pharmaceuticals, Inc.

10.2.5 ElexoPharm GmbH

10.2.6 Ipsen S.A.

10.2.7 Isis Pharmaceuticals, Inc.

10.2.8 Novartis AG

10.2.9 Orphagen Pharmaceuticals, Inc.

10.2.10 Pfizer Inc.

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Pituitary ACTH Hypersecretion Drug Product Type Overview

Table Pituitary ACTH Hypersecretion Drug Product Type Market Share List

Table Pituitary ACTH Hypersecretion Drug Product Type of Major Players

Table Brief Introduction of Alder Biopharmaceuticals Inc.

Table Brief Introduction of Corcept Therapeutics Incorporated

Table Brief Introduction of Cortendo AB

Table Brief Introduction of Cyclacel Pharmaceuticals, Inc.

Table Brief Introduction of ElexoPharm GmbH

Table Brief Introduction of Ipsen S.A.

Table Brief Introduction of Isis Pharmaceuticals, Inc.

Table Brief Introduction of Novartis AG

Table Brief Introduction of Orphagen Pharmaceuticals, Inc.

Table Brief Introduction of Pfizer Inc.

Table Products & Services of Alder Biopharmaceuticals Inc.

Table Products & Services of Corcept Therapeutics Incorporated

Table Products & Services of Cortendo AB

Table Products & Services of Cyclacel Pharmaceuticals, Inc.

Table Products & Services of ElexoPharm GmbH

Table Products & Services of Ipsen S.A.

Table Products & Services of Isis Pharmaceuticals, Inc.

Table Products & Services of Novartis AG

Table Products & Services of Orphagen Pharmaceuticals, Inc.

Table Products & Services of Pfizer Inc.

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Pituitary ACTH Hypersecretion Drug Market Forecast (Million USD) by Region 2021f-2026f

Table Global Pituitary ACTH Hypersecretion Drug Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Pituitary ACTH Hypersecretion Drug Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Pituitary ACTH Hypersecretion Drug Market Forecast (Million USD) Share by Demand 2021f-2026f